REVENUE (Tables)

6 Months Ended

Jun. 30, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Revenue by Segment by Geographic Area

Revenue by segment and geography based on shipped to locations for the three and six months ended June 30, 2025 and 2024 were as follows:

	For the Three Months Ended June 30, 2025
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	211,829	$	161,162	$	13,520	$	56,078	$	442,589
Aptar Beauty	205,236		56,832		42,907		29,874		334,849
Aptar Closures	58,930		91,755		19,715		18,171		188,571
Total	$	475,995	$	309,749	$	76,142	$	104,123	$	966,009

	For the Three Months Ended June 30, 2024
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	207,493	$	138,734	$	13,301	$	55,005	$	414,533
Aptar Beauty	190,740		66,618		42,207		21,922		321,487
Aptar Closures	51,894		84,468		22,283		15,398		174,043
Total	$	450,127	$	289,820	$	77,791	$	92,325	$	910,063

	For the Six Months Ended June 30, 2025
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	410,522	$	302,823	$	25,501	$	113,210	$	852,056
Aptar Beauty	393,145		115,029		82,493		49,889		640,556
Aptar Closures	110,974		174,354		40,662		34,712		360,702
Total	$	914,641	$	592,206	$	148,656	$	197,811	$	1,853,314

	For the Six Months Ended June 30, 2024
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	419,668	$	264,544	$	25,923	$	111,691	$	821,826
Aptar Beauty	396,930		129,895		80,394		41,588		648,807
Aptar Closures	107,921		173,284		43,556		30,117		354,878
Total	$	924,519	$	567,723	$	149,873	$	183,396	$	1,825,511

Schedule of Contract Assets and Contract Liabilities

The opening and closing balances of our contract asset and contract liabilities were as follows:

	Balance as of June 30, 2025		Balance as of December 31, 2024		Increase/ (Decrease)
Contract asset (current)	$	11,785	$	12,571	$	(786)
Contract liability (current)	85,373		64,425		20,948
Contract liability (long-term)	50,660		40,551		10,109